Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07141394Enrolling by invitation
Randomised, open-label trial in substance use disorder (SUD) (3 arms), sponsored by VA Office of Research & Development. Primary endpoints: Reach of Medications for Addiction Treatment at 18 months, Reach of Cognitive Behavioral Therapy-Substance Use Disorders at 18 months and 4 more. Started Sep 2026; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07141394.